BurnA
Senior Member
- Messages
- 2,087
So, if you could change something would it be a) remove Walitt
B) remove FMD group
C) increase ME patient number
B) remove FMD group
C) increase ME patient number
D) all of the above?So, if you could change something would it be a) remove Wallit
B) remove FMD group
C) increase ME patient number
That's too easy. We all want that.D) all of the above?
I would really like NIH to provide more info about why they have picked the post-Lyme and FMD groups. At the moment I am worried about the inclusion of the FMD group. Perhaps it's a great opportunity for more research into FMD - trying to find physical causes....but given that their own draft protocol states that this is a group with psychosomatic causation, I feel concerned.
They are being selected by expert clinicians, apparently.
If I heard correctly, the patients will be recruited from the same centers involved in the CDC multisite study. Someone correct me if I'm wrong.Do we know this for sure? One would hope...
Strange how Nath described the Norwegian studies as small, yet the patient no.s are not too different.
Strange how Nath described the Norwegian studies as small, yet the patient no.s are not too different.
Yes, particularly as Fluge and Mella were trialling a treatment and have stepped up the number of participants for the Phase III, where as the NIH study is going fishing and will be making an incalculable (for me at any rate) number of comparisons. The later phases of the NIH project should deal with the false positives but with such a small number of patients, I'm pondering (without any success) how likely it will be that something important might be missed at this initial stage.Strange how Nath described the Norwegian studies as small, yet the patient no.s are not too different.
Actually, I'm quite happy to have researchers to be biased in that they have read the literature and realize this is a serious multi systemic biological illness. : )Researchers should be agnostic. As in judicial proceedings where impartiality is an issue, judges recluse themselves. I have problems with any researcher exhibiting pre-existing confirmation bias with regards to ME/CFS research. I find this troubling. Confirmation bias is a form of cognitive bias and as such is deeply rooted in ones way of thinking. Good scientific practices can diminish the effect of this bias, but they are not always followed nor infallible.
\
Actually, I'm quite happy to have researchers to be biased in that they have read the literature and realize this is a serious multi systemic biological illness. : )
But I know what you meant. The psychobabblers must go !
Confirmation bias is when a researcher holds a stronghly held view that through his prior research that ME/CFS is caused by psychosomatic disorder and not a biological disorder when conducting current research on ME/CFS
Although I would like the NIH study to be bigger I think that treatment studies need to be much bigger than the discovery studies. So phase iii of this study will be have many more patient than 40. And the NIH rituximab trial should be bigger too.
Interesting to read a first-hand account of FMD. I notice that the patient experiences fatigue:I also find the FMD control group deeply troubling since there is no underlying exact cause for FMD other than wastebasket of mental illness considering the ME/CFS physical symptoms are mild compared to those in the FMD group, especially after viewing aspects of this website http://www.functionalmovementdisorder.com/welcome/an-update-on-me/